![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | G01N 33/566 | |
C07K 16/28 |
(11) | Number of the document | 3304079 |
(13) | Kind of document | T |
(96) | European patent application number | 16731700.7 |
Date of filing the European patent application | 2016-06-02 | |
(97) | Date of publication of the European application | 2018-04-11 |
(45) | Date of publication and mention of the grant of the patent | 2020-06-03 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/035514 |
Date | 2016-06-02 |
(87) | Number | WO 2016/196792 |
Date | 2016-12-08 |
(30) | Number | Date | Country code |
201562170579 P | 2015-06-03 | US |
(72) |
WANG, Xi-tao, US
ADELAKUN, Olufemi, A., US
LEWIN, Anne, C., US
KORMAN, Alan, J., US
SELBY, Mark, J., US
WANG, Changyu, US
HUANG, Haichun, US
HENNING, Karla, A., US
LONBERG, Nils, US
SRINIVASAN, Mohan, US
HAN, Michelle, Minhua, US
CHEN, Guodong, US
HUANG, Richard, US
CHAKRABORTY, Indrani, US
WONG, Susan, Chien-Szu, US
LI, Huiming, US
|
(73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
(54) | ANTI-GITR ANTIBODIES FOR CANCER DIAGNOSTICS |
ANTI-GITR ANTIBODIES FOR CANCER DIAGNOSTICS |